Plans Advance for Biomarkers Panel to Assess Drug-induced Skeletal Muscle Injury
Aug 07, 2020, 12:00 AM
SMA News Today’s multimedia associate, Price Wooldridge, discusses plans being advanced for a biomarkers panel to assess drug-induced skeletal muscle injury in SMA.
Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/